These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 34598656)
21. Single dose planning for radioiodine-131 therapy of Graves' disease. Kita T; Yokoyama K; Kinuya S; Taki J; Michigishi T; Tonami N Ann Nucl Med; 2004 Apr; 18(2):151-5. PubMed ID: 15195763 [TBL] [Abstract][Full Text] [Related]
22. Correlation of radioiodine doses for 6-hr and 24-hour iodine-131 thyroid uptake values for Graves' hyperthyroidism. Horn-Lodewyk J Endocr J; 2019 Dec; 66(12):1047-1052. PubMed ID: 31391354 [TBL] [Abstract][Full Text] [Related]
28. Graves' disease and radioiodine therapy. Is success of ablation dependent on the achieved dose above 200 Gy? Kobe C; Eschner W; Sudbrock F; Weber I; Marx K; Dietlein M; Schicha H Nuklearmedizin; 2008; 47(1):13-7. PubMed ID: 18278207 [TBL] [Abstract][Full Text] [Related]
29. Success rate of radioiodine therapy in Graves' disease: the influence of thyrostatic medication. Sabri O; Zimny M; Schulz G; Schreckenberger M; Reinartz P; Willmes K; Buell U J Clin Endocrinol Metab; 1999 Apr; 84(4):1229-33. PubMed ID: 10199759 [TBL] [Abstract][Full Text] [Related]
30. Onset age is associated with outcome of radioiodine therapy in Graves' disease. Yamashita Y; Yamane K; Tamura T; Okubo M; Kohno N Endocr J; 2004 Apr; 51(2):127-32. PubMed ID: 15118261 [TBL] [Abstract][Full Text] [Related]
31. Pattern of recovery of the hypothalamic-pituitary-thyroid axis following radioactive iodine therapy in patients with Graves' disease. Uy HL; Reasner CA; Samuels MH Am J Med; 1995 Aug; 99(2):173-9. PubMed ID: 7625422 [TBL] [Abstract][Full Text] [Related]
32. Clinical and Dosimetric Variables Related to Outcome After Treatment of Graves' Disease With 550 and 1110 MBq of 131I: Results of a Prospective Randomized Trial. Sapienza MT; Coura-Filho GB; Willegaignon J; Watanabe T; Duarte PS; Buchpiguel CA Clin Nucl Med; 2015 Sep; 40(9):715-9. PubMed ID: 26204202 [TBL] [Abstract][Full Text] [Related]
33. [F-qi-FDG PET of the thyroid gland in Graves' disease]. Börner AR; Voth E; Wienhard K; Wagner R; Schicha H Nuklearmedizin; 1998; 37(7):227-33. PubMed ID: 9830612 [TBL] [Abstract][Full Text] [Related]
34. The influence of non-radioactive iodine (127I) on the outcome of radioiodine (131I) therapy in patients with Graves' disease and toxic nodular goitre. Rogowski F; Abdelrazek S; Szumowski P; Zonenberg A; Parfienczyk A; Sawicka A Nucl Med Rev Cent East Eur; 2011; 14(1):9-15. PubMed ID: 21751166 [TBL] [Abstract][Full Text] [Related]
36. [The outcome of treatment with adjusted dose of 131I to thyroid weight for Graves' disease by estimation of effective half life using a single radioiodine uptake measurement]. Gomi Y; Watanabe M; Yoshimura H; Ishikawa N; Momotani N; Ito K; Inoue T; Ito K; Suzuki S Kaku Igaku; 2000 Mar; 37(2):109-14. PubMed ID: 10783569 [TBL] [Abstract][Full Text] [Related]
37. [Determination of factors affecting the therapeutic outcome of radioiodine therapy in patients with Graves' disease]. Sabri O; Schulz G; Zimny M; Schreckenberger M; Zimny D; Wagenknecht G; Kaiser HJ; Dohmen BM; Bares R; Büll U Nuklearmedizin; 1998 May; 37(3):83-9. PubMed ID: 9604227 [TBL] [Abstract][Full Text] [Related]
38. Radioactive iodine therapy for pediatric Graves' disease: a single-center experience over a 10-year period. Kaplowitz PB; Jiang J; Vaidyanathan P J Pediatr Endocrinol Metab; 2020 Mar; 33(3):383-389. PubMed ID: 31603857 [TBL] [Abstract][Full Text] [Related]
39. A randomized comparison of radioiodine doses in Graves' hyperthyroidism. Leslie WD; Ward L; Salamon EA; Ludwig S; Rowe RC; Cowden EA J Clin Endocrinol Metab; 2003 Mar; 88(3):978-83. PubMed ID: 12629071 [TBL] [Abstract][Full Text] [Related]
40. The development of transient hypothyroidism after iodine-131 treatment in hyperthyroid patients with Graves' disease: prevalence, mechanism and prognosis. Aizawa Y; Yoshida K; Kaise N; Fukazawa H; Kiso Y; Sayama N; Hori H; Abe K Clin Endocrinol (Oxf); 1997 Jan; 46(1):1-5. PubMed ID: 9059550 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]